ArticleScientific reports2015

MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer.

Xiaoqian Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.